Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Drug-coated Balloon Angioplasty Becomes First-line Treatment for Coronary Artery Disease Leading Vendors to Acquire Drug-coated Balloon Companies

September 5, 2016 By Technavio Research

Technavio analysts forecast the global angioplasty balloons market to grow at a moderate CAGR of over 3 percent during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global angioplasty balloons market for 2016-2020. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors operating in the market.

Drug-coated balloon angioplasty has become a first-line treatment for coronary artery disease (CAD). This has led vendors to acquire companies that offer drug-coated balloons. For instance, Spectranetics acquired AngioScore for $230 million in June 2014 and Covidien’s Stellarex line of drug-coated angioplasty balloons for $30 million in January 2015. These acquisitions will lead Spectranetics to become a major competitor for Tier 1 companies during the forecast period.

Technavio healthcare and life sciences analysts highlight the following four factors that are contributing to the growth of the global angioplasty balloons market:

  • Incidence of cardiac diseases and adoption of PCI
  • Presence of specialized cardiologists
  • Outsourcing research studies on PCI devices to CROs
  • Venture capitals for market entry of start-ups and small companies

Request a sample report:http://www.technavio.com/request-a-sample?report=52564

Technavio’s sample reports are free of charge and contain multiple sections of the report including market size and forecast, drivers, challenges, trends, and more.

Incidence of cardiac diseases and adoption of PCI

The incidence of cardiac diseases is on the rise worldwide. In 2015, the CDC estimated that these diseases caused about 610,000 deaths in the U.S. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the U.S. annually.

For treating coronary heart disease, physicians perform coronary angioplasty and stenting, a part of percutaneous coronary intervention (PCI), for diagnosis. These procedures help confirm the severity of the disease, with the physician performing coronary stenting to treat the blocked arteries. Angiography involves the insertion of balloon catheters to widen the narrowing arterial walls that can obstruct normal blood flow. Physicians may insert stents to keep the blood vessel open. This procedure helps reduce the risk of stroke in people with CAD.

Srinivas Sashidhar, a lead cardiovascular devices research analyst at Technavio, says, “The rise in the cases of cardiac disorders will increase the volume of treatment procedures that include disease diagnosis and cardiac surgeries. This will increase the number of PCI procedures, which will lead to the demand, sales, and use of angioplasty balloons.”

Presence of specialized cardiologists

“Cardiologists specializing in the treatment of diseases and conditions of the heart and blood vessels are required for cardiovascular procedures. Many hospitals and cardiac centers worldwide, particularly in emerging countries, have highly skilled cardiologists who perform successful procedures. They are opting for interventional techniques to treat various CVDs due to their less invasive nature,” adds Srinivas.

Hospitals use established cardiology procedures such as percutaneous transluminal coronary angioplasty ( PTCA ), diagnostic angiography, and coronary stenting to treat individuals with CADs. Many vendors are expanding into developing countries due to the presence of experienced surgeons who can efficiently use angioplasty balloons for treating CADs. Vendors are also conducting medical education programs and practice sessions to train surgeons in surgical techniques and device implantation.

Outsourcing research studies on PCI devices to CROs

Medical device manufacturing companies outsource their research activities and clinical trials to contract research organizations (CROs). These organizations can be individual contract research companies or universities that conduct clinical research. The business relation between CROs and manufacturers is based on their product deliverables.

CROs used to only conduct clinical trials to evaluate the safety and efficacy of balloon catheters and stents. However, these organizations are now helping manufacturers in developing these devices. They are also engaging in tie-ups with regulatory agencies for pre- and post-market approvals of balloon catheters and stents, which help minimize the duration of regulatory approval.

Venture capitals for market entry of start-ups and small companies

New players approach venture capitalists to enter into niche markets such as the area of angioplasty balloons. These capitalists have started realizing the significant potential of start-ups that develop innovative technologies and products in the area of CVDs. This has increased the financial flow support from venture capitalists, which is accelerating the development of embolic protection devices and is leading to the market entry of start-ups. Post registration and market approvals, venture capitalists take a share from the total revenue generated by the start-ups.

Top vendors:

  • Abbott Laboratories
  • Boston Scientific
  • C. R. Bard
  • Medtronic

Browse Related Reports:

  • Global Coronary Artery Disease Treatment Devices Market 2015-2019
  • Global Stent Grafts Market 2015-2019
  • PTCA Balloon Catheter Market in China 2015-2019

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

(Source: Business Wire)

Related Articles Read More >

Min-Vasive Medtech: Live interviews and audience Q&As with minimally invasive engineers from Edwards Lifesciences, Jupiter Endo and Compremium
An illustration of Embolization Inc.'s Nitinol Enhanced Device (NED).
This nitinol vascular embolization device has another shape memory material up its sleeve
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
July 2025 edition: The Surgical Robotics issue, featuring Capstan Medical, J&J and Zimmer Biomet
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe